For example, in liver diseases, FSTL1 exacerbates fibrosis by promoting inflammatory macrophage polarization and attenuating mesenchymal stem cell (MSC)-mediated immunosuppression (Sun et al., 2023; Gu et al., 2023; Zheng et al., 2022). This evidence concerns the gene FSTL1 and liver disorder.